Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $3.996B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 21,751,284 | $1.314B | 32.9% | — | — | CLASS A ORD | 61559X104 |
| RVMD | REVOLUTION MEDICINES INC | 5,981,212 | $172M | 4.3% | — | — | COM | 76155X100 |
| AXSM | AXSOME THERAPEUTICS INC | 1,981,100 | $158M | 3.9% | — | — | COM | 05464T104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 5,744,848 | $132M | 3.3% | — | — | COM | 74366E102 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $131M | 3.3% | — | — | COM | 501575104 |
| MIRM | MIRUM PHARMACEUTICALS INC | 4,370,024 | $129M | 3.2% | — | — | COM | 604749101 |
| OLMA | OLEMA PHARMACEUTICALS INC | 9,135,893 | $128M | 3.2% | — | — | COM | 68062P106 |
| IONS | IONIS PHARMACEUTICALS INC | 2,428,613 | $123M | 3.1% | — | — | COM | 462222100 |
| KURA | KURA ONCOLOGY INC | 7,373,228 | $106M | 2.7% | — | — | COM | 50127T109 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,007,413 | $81.19M | 2.0% | — | — | COM | 35104E100 |
| GLPG | GALAPAGOS NV | 1,915,109 | $77.85M | 1.9% | — | — | SPON ADR | 36315X101 |
| — | MERUS N V | 2,752,420 | $75.69M | 1.9% | — | — | COM | N5749R100 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $75.44M | 1.9% | — | — | COM | 760273102 |
| ACIU | AC IMMUNE SA | 14,571,236 | $72.86M | 1.8% | — | — | SHS | H00263105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 8,774,570 | $69.85M | 1.7% | — | — | SPONSORED ADS | 152309100 |
| XOMA | XOMA CORP DEL | 3,633,743 | $67.22M | 1.7% | — | — | COM NEW | 98419J206 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,729,043 | $61.52M | 1.5% | — | — | COM | 45166A102 |
| ZYME | ZYMEWORKS INC | 5,870,000 | $60.99M | 1.5% | — | — | COM | 98985Y108 |
| GHRS | GH RESEARCH PLC | 10,400,158 | $60.32M | 1.5% | — | — | ORDINARY SHARES | G3855L106 |
| — | ESSA PHARMA INC | 8,748,629 | $57.74M | 1.4% | — | — | COM NEW | 29668H708 |
| JANX | JANUX THERAPEUTICS INC | 4,579,818 | $49.14M | 1.2% | — | — | COM | 47103J105 |
| — | THIRD HARMONIC BIO INC | 4,365,933 | $47.89M | 1.2% | — | — | COM | 88427A107 |
| — | 89BIO INC | 4,047,354 | $45.21M | 1.1% | — | — | COM | 282559103 |
| RLAY | RELAY THERAPEUTICS INC | 3,970,045 | $43.71M | 1.1% | — | — | COM | 75943R102 |
| XENE | XENON PHARMACEUTICALS INC | 890,072 | $41M | 1.0% | — | — | COM | 98420N105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,875,000 | $40.52M | 1.0% | — | — | COM | 87164F105 |
| TYRA | TYRA BIOSCIENCES INC | 2,739,595 | $37.94M | 0.9% | — | — | COM | 90240B106 |
| LXRX | LEXICON PHARMACEUTICALS INC | 24,435,632 | $37.39M | 0.9% | — | — | COM NEW | 528872302 |
| GPCR | STRUCTURE THERAPEUTICS INC | 812,988 | $33.14M | 0.8% | — | — | SPONSORED ADS | 86366E106 |
| CGEM | CULLINAN ONCOLOGY INC | 3,196,701 | $32.57M | 0.8% | — | — | COM | 230031106 |
| ANTX | AN2 THERAPEUTICS INC | 1,563,963 | $32.05M | 0.8% | — | — | COM | 037326105 |
| ANNX | ANNEXON INC | 7,000,000 | $31.78M | 0.8% | — | — | COM | 03589W102 |
| ROIV | ROIVANT SCIENCES LTD | 2,742,409 | $30.8M | 0.8% | — | — | SHS | G76279101 |
| SLN | SILENCE THERAPEUTICS PLC | 1,508,416 | $26.2M | 0.7% | — | — | ADS | 82686Q101 |
| — | ALLAKOS INC | 8,552,417 | $23.35M | 0.6% | — | — | COM | 01671P100 |
| — | GLYCOMIMETICS INC | 9,544,262 | $22.52M | 0.6% | — | — | COM | 38000Q102 |
| OVID | OVID THERAPEUTICS INC | 6,851,051 | $22.06M | 0.6% | — | — | COM | 690469101 |
| ENGN | ENGENE HOLDINGS INC | 2,251,037 | $20.78M | 0.5% | — | — | COM | 29286M105 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $19.33M | 0.5% | — | — | SPONSERED ADS | 13124Q106 |
| TCRX | TSCAN THERAPEUTICS INC | 2,989,474 | $17.43M | 0.4% | — | — | COM | 89854M101 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1,521,948 | $17M | 0.4% | — | — | ORDINARY SHARES | N62509109 |
| SYRE | SPYRE THERAPEUTICS INC | 687,080 | $14.79M | 0.4% | — | — | COM NEW | 00773J202 |
| — | SUTRO BIOPHARMA INC | 3,347,946 | $14.36M | 0.4% | — | — | COM | 869367102 |
| — | ITEOS THERAPEUTICS INC | 1,259,476 | $13.79M | 0.3% | — | — | COM | 46565G104 |
| VSTM | VERASTEM INC | 1,685,219 | $13.72M | 0.3% | — | — | COM NEW | 92337C203 |
| IMVT | IMMUNOVANT INC | 300,000 | $12.64M | 0.3% | — | — | COM | 45258J102 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,000,000 | $10.28M | 0.3% | — | — | COM | 92840H400 |
| CTMX | CYTOMX THERAPEUTICS INC | 6,595,801 | $10.22M | 0.3% | — | — | COM | 23284F105 |
| — | IKENA ONCOLOGY INC | 4,769,164 | $9.395M | 0.2% | — | — | COM | 45175G108 |
| — | VERVE THERAPEUTICS INC | 650,000 | $9.061M | 0.2% | — | — | COM | 92539P101 |
| ELDN | ELEDON PHARMACEUTICALS INC | 4,326,710 | $7.788M | 0.2% | — | — | COM | 28617K101 |
| — | SAB BIOTHERAPEUTICS INC | 9,178,282 | $6.31M | 0.2% | — | — | COM | 78397T103 |
| — | VIGIL NEUROSCIENCE INC | 1,813,633 | $6.13M | 0.2% | — | — | COM | 92673K108 |
| — | CIDARA THERAPEUTICS INC | 6,861,127 | $5.448M | 0.1% | — | — | COM | 171757107 |
| — | RAIN ONCOLOGY INC | 3,526,729 | $4.232M | 0.1% | — | — | COM | 75082Q105 |
| DCTH | DELCATH SYS INC | 976,149 | $4.061M | 0.1% | — | — | COM NEW | 24661P807 |
| — | PIERIS PHARMACEUTICALS INC | 20,609,863 | $3.751M | 0.1% | — | — | COM | 720795103 |
| — | KRONOS BIO INC | 2,905,043 | $3.631M | 0.1% | — | — | COM | 50107A104 |
| — | NLS PHARMACEUTICS LTD | 5,747,126 | $3.39M | 0.1% | — | — | SHS | H57830103 |
| IVA | INVENTIVA SA | 686,040 | $3.073M | 0.1% | — | — | ADS | 46124U107 |
| — | FORTE BIOSCIENCES INC | 2,982,105 | $2.45M | 0.1% | — | — | COM | 34962G109 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,370,947 | $2.413M | 0.1% | — | — | COM | 221015100 |
| — | VIRACTA THERAPEUTICS INC | 3,614,662 | $2.06M | 0.1% | — | — | COM | 92765F108 |
| — | MOLECULAR TEMPLATES INC | 532,038 | $1.969M | 0.0% | — | — | COM NEW | 608550208 |
| — | UNICYCIVE THERAPEUTICS INC | 2,118,139 | $1.838M | 0.0% | — | — | COM | 90466Y103 |
| MOLN | MOLECULAR PARTNERS AG | 443,221 | $1.764M | 0.0% | — | — | ADS | 60853G106 |
| — | ELEVATION ONCOLOGY INC | 2,312,200 | $1.242M | 0.0% | — | — | COM | 28623U101 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $804K | 0.0% | — | — | *W EXP 10/31/202 | 29286M113 |
| — | ASLAN PHARMACEUTICALS LTD | 1,049,999 | $548K | 0.0% | — | — | SPON ADS NEW | 04522R200 |
| RZLT | REZOLUTE INC | 190,815 | $189K | 0.0% | — | — | COM NEW | 76200L309 |